Luciano Adorini

Intercept Pharmaceuticals (United States)

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2”.

Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2

American Journal of Physiology-Gastrointestinal and Liver Physiology(2023)10.1152/ajpgi.00099.2023

N/A

0.406DataRank · unranked

7 citations

Jennifer K. Truong, Anuradha Rao, Ruxian Lin, Jennifer Foulke‐Abel, Luciano Adorini +4 more

The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102530

N/A

0DataRank · unranked

57 citations

Cen Xie, Andrew E. Libby, Suman Ranjit, Jonathan Levi, Komuraiah Myakala +20 more